JPMorgan Chase & Co.'s Rating of NOV on 7/30/2025

On July 30, 2025, JPMorgan Chase & Co. updated its outlook on NOV (NYSE:NOV) with the action "Downgrade", setting a "Neutral" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from JPMorgan Chase & Co.

DateCompanyAction
11/16/2026
Telephone and Data Systems, Inc. stock logo
TDS
Telephone and Data Systems
Lower Price Target
11/16/2026
Ovintiv Inc. stock logo
OVV
Ovintiv
Set Price Target
11/16/2026
KANZHUN LIMITED Sponsored ADR stock logo
BZ
KANZHUN
Lower Price Target
11/16/2026
Omada Health, Inc. stock logo
OMDA
Omada Health
Lower Price Target
11/16/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Lower Price Target
11/16/2026
Sigma Lithium Corporation stock logo
SGML
Sigma Lithium
Lower Price Target
More Ratings From JPMorgan Chase & Co.